ClinicalTrials.Veeva

Menu

Efficacy of Magnetic Imaging Colonoscopy Applied to Beginner Endoscopists

K

Korea University

Status

Enrolling

Conditions

Colonic Neoplasms

Treatments

Device: Navigation screen
Device: ScopeGuide Navigated Colonoscope

Study type

Interventional

Funder types

Other

Identifiers

NCT05746962
2022AN0126

Details and patient eligibility

About

Magnetic endoscopic imaging (scopeguide) is known to be helpful for colonoscope insertion, especially beginner endoscopist. In this trial, study was designed to show the efficacy and safety pertinent to scopeguide use in detail.

Full description

Colorectal cancer is one of the most commonly diagnosed malignancies worldwide. Colorectal cancer screening significantly reduced the incidence and mortality, and colonoscopy is generally recognized as a standard method. Among them, magnetic endoscopic imaging (MEI, Scopeguide, Magnetic Enhanced Instrument, Olympus, Japan) is a non-radiological imaging instrument that can display the three-dimensional configuration and position of the colonoscope in the abdominal cavity in real time. This study aims to investigate the effectiveness of colonoscopy by measuring the insertion-related index of the colonoscopy according to the scope guide for only beginners of endoscopy.

Enrollment

128 estimated patients

Sex

All

Ages

19 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age 19-80
  • the patient who visit to examine the colonoscopy

Exclusion criteria

  • the patient who has a pacemaker
  • the patient who has electronic devices in the body
  • bowel obstruction and bleeding
  • glomerulus filter rate < 30
  • inflammatory bowel disease, pregnancy
  • previous history of bowel resection and abdominal surgery
  • who refuse to write the informed consent
  • previous history of allergic reaction to sedative drugs and beans, egg
  • SBP <80, SpO2<90

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

128 participants in 2 patient groups

Group that does not use the scopeguide screen
Active Comparator group
Description:
The control group should remove the looping of colonoscope by looking at the general colonoscopy screen The control group cannot use scopeguide screen Scopeguide screen is blinded by an opaque wrapping paper
Treatment:
Device: ScopeGuide Navigated Colonoscope
Group using the scopeguide screen
Experimental group
Description:
The experimental group uses a general endoscopic image during colonoscopic insertion The experimental group should remove the looping of colonoscope by looking at the scopeguide screen
Treatment:
Device: ScopeGuide Navigated Colonoscope
Device: Navigation screen

Trial contacts and locations

1

Loading...

Central trial contact

Bora Keum

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems